Experience Matters.
Lawrence Blatt
Non-Executive Director
Co-founded Alios BioPharma, Inc., and led the company from inception to acquisition by Johnson & Johnson.
Iain D. Dukes
Non-Executive Director
Holds multiple Board/CEO positions, alongside world-class licensing experience including at Merck & Co. and Amgen Inc.
Ron Hunt
Managing Director, New Leaf Venture Partners
Founder of New Leaf Venture Partners with over 20 years investment and company-building experience.
Richard N. Kender
Non-Executive Director
Involved in over 100 Business Development & Corporate Licensing transactions during 35 year tenure at Merck & Co.
Chau Q. Khuong
Private Equity Partner, OrbiMed
Experienced investor focused on structured investments across private and public biopharmaceutical and medical device companies.
Nanna Lüneborg
Partner, Novo Holdings
Highest quality investments including successful public listings of Orphazyme (ORPHA) and ObsEva (OBSV).
Dr. Ken Powell
Chairman
Founded and led Arrow Therapeutics Ltd to $150 million acquisition by AstraZeneca.
Alex C. Sapir
Chief Executive Officer
Grew small biotech start-up with upside to 150-person, publicly-traded company with approved, marketed product.
Raphaël Wisniewski
Partner, Andera Partners
Top pedigree investments, IPOs and trade sales over 19 years with Andera Partners.